Literature DB >> 28558375

The Determinants of Quality of Life of Nursing Home Residents with Young-Onset Dementia and the Differences between Dementia Subtypes.

Britt Appelhof1, Christian Bakker, Jeannette C L Van Duinen-van den Ijssel, Sandra A Zwijsen, Martin Smalbrugge, Frans R J Verhey, Marjolein E de Vugt, Sytse U Zuidema, Raymond T C M Koopmans.   

Abstract

AIMS: The aims of this study are to (1) explore the determinants of quality of life (QoL) in nursing home residents with young-onset dementia (YOD), (2) investigate whether there are differences between dementia subtypes (Alzheimer dementia, vascular/mixed dementia, frontotemporal dementia, other) regarding these determinants, and (3) compare QoL profiles of YOD nursing home residents across dementia subtypes.
METHODS: This cross-sectional study included 207 nursing home residents. Multilevel modeling was used to determine the relationships between QoL and neuropsychiatric symptoms (NPS), dementia severity, psychotropic drug use (PDU), dementia subtype, age, and gender. Additional multilevel models were used to compare aspects of QoL between dementia subtypes.
RESULTS: Residents' QoL was negatively associated with advanced dementia, PDU, and NPS. In general, the relationships between the determinants and QoL were similar across the dementia subtypes. Aspects of QoL differed by dementia subtype. Residents with frontotemporal dementia showed less negative emotions, accepted more help and experienced better quality of relationships with professional caregivers, had a more positive self-image, felt more comfortable in the nursing home environment, and experienced lower quality of social relationships.
CONCLUSIONS: Considering the high rates of NPS and PDU in YOD residents and their negative associations with QoL, we recommend emphasizing services to manage and reduce NPS and PDU in nursing home residents with YOD. Furthermore, our findings suggest accounting for differences in aspects of QoL by dementia subtype to address specific needs and thereby improve QoL.
© 2017 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Neuropsychiatric symptoms; Nursing home; Psychotropic drugs; Quality of life; Young-onset dementia

Mesh:

Year:  2017        PMID: 28558375     DOI: 10.1159/000477087

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  7 in total

1.  Relationship between the severity of agitation and quality of life in residents with dementia living in German nursing homes - a secondary data analysis.

Authors:  Kathrin Schmüdderich; Daniela Holle; Armin Ströbel; Bernhard Holle; Rebecca Palm
Journal:  BMC Psychiatry       Date:  2021-04-13       Impact factor: 3.630

2.  Quality of Life in Advanced Dementia with Late Onset, Young Onset, and Very Young Onset.

Authors:  Julia Hartmann; Carola Roßmeier; Lina Riedl; Bianca Dorn; Julia Fischer; Till Slawik; Mareike Fleischhaker; Florentine Hartmann; Silvia Egert-Schwender; Victoria Kehl; Bernhard Haller; Helga Schneider-Schelte; Andreas Dinkel; Ralf J Jox; Janine Diehl-Schmid
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  Concordance of self- and informant-rated depressive symptoms in nursing home residents with Dementia: cross-sectional findings.

Authors:  Julie L O'Sullivan; Roxana Schweighart; Sonia Lech; Eva-Marie Kessler; Christina Tegeler; Andrea Teti; Johanna Nordheim; Paul Gellert
Journal:  BMC Psychiatry       Date:  2022-04-05       Impact factor: 3.630

4.  Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial.

Authors:  Matthew J Leach; Merrian Sangalli; Ian Breakspear; Sandra Walsh
Journal:  Integr Med Res       Date:  2021-05-26

5.  Quality of life in people with dementia living in nursing homes: validation of an eight-item version of the QUALIDEM for intensive longitudinal assessment.

Authors:  Stefan Junge; Paul Gellert; Julie Lorraine O'Sullivan; Sebastian Möller; Jan-Niklas Voigt-Antons; Adelheid Kuhlmey; Johanna Nordheim
Journal:  Qual Life Res       Date:  2020-01-18       Impact factor: 4.147

6.  Cost-consequence analysis of an intervention for the management of neuropsychiatric symptoms in young-onset dementia: Results from the BEYOND-II study.

Authors:  Jeannette C L van Duinen-van den IJssel; Christian Bakker; Martin Smalbrugge; Sandra A Zwijsen; Eddy Adang; Britt Appelhof; Sytse U Zuidema; Marjolein E de Vugt; Frans R J Verhey; Raymond T C M Koopmans
Journal:  Int J Geriatr Psychiatry       Date:  2019-11-07       Impact factor: 3.485

7.  End Stage Clinical Features and Cause of Death of Behavioral Variant Frontotemporal Dementia and Young-Onset Alzheimer's Disease.

Authors:  Marie-Paule E van Engelen; Flora T Gossink; Lieke S de Vijlder; Jan R A Meursing; Philip Scheltens; Annemiek Dols; Yolande A L Pijnenburg
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.